Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8655955rdf:typepubmed:Citationlld:pubmed
pubmed-article:8655955lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:8655955lifeskim:mentionsumls-concept:C0014264lld:lifeskim
pubmed-article:8655955lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:8655955lifeskim:mentionsumls-concept:C1442792lld:lifeskim
pubmed-article:8655955lifeskim:mentionsumls-concept:C1623038lld:lifeskim
pubmed-article:8655955pubmed:issue4lld:pubmed
pubmed-article:8655955pubmed:dateCreated1996-7-31lld:pubmed
pubmed-article:8655955pubmed:abstractTextThe factors which trigger the hyperdynamic circulation in cirrhosis remain poorly defined. Plasma levels of the potent vasodilators endotoxin and tumor necrosis factor-alpha may be elevated in patients with cirrhosis, and therefore the potential role of these substance was assessed in the hyperkinetic circulation in cirrhosis.lld:pubmed
pubmed-article:8655955pubmed:languageenglld:pubmed
pubmed-article:8655955pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8655955pubmed:citationSubsetIMlld:pubmed
pubmed-article:8655955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8655955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8655955pubmed:statusMEDLINElld:pubmed
pubmed-article:8655955pubmed:monthOctlld:pubmed
pubmed-article:8655955pubmed:issn0168-8278lld:pubmed
pubmed-article:8655955pubmed:authorpubmed-author:GoldmanMMlld:pubmed
pubmed-article:8655955pubmed:authorpubmed-author:MoreauRRlld:pubmed
pubmed-article:8655955pubmed:authorpubmed-author:LebrecDDlld:pubmed
pubmed-article:8655955pubmed:authorpubmed-author:HadengueAAlld:pubmed
pubmed-article:8655955pubmed:authorpubmed-author:SogniPPlld:pubmed
pubmed-article:8655955pubmed:authorpubmed-author:MarchantAAlld:pubmed
pubmed-article:8655955pubmed:authorpubmed-author:Le MoineOOlld:pubmed
pubmed-article:8655955pubmed:authorpubmed-author:DevièreJJlld:pubmed
pubmed-article:8655955pubmed:authorpubmed-author:SoupisonTTlld:pubmed
pubmed-article:8655955pubmed:issnTypePrintlld:pubmed
pubmed-article:8655955pubmed:volume23lld:pubmed
pubmed-article:8655955pubmed:ownerNLMlld:pubmed
pubmed-article:8655955pubmed:authorsCompleteYlld:pubmed
pubmed-article:8655955pubmed:pagination391-5lld:pubmed
pubmed-article:8655955pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8655955pubmed:meshHeadingpubmed-meshheading:8655955-...lld:pubmed
pubmed-article:8655955pubmed:meshHeadingpubmed-meshheading:8655955-...lld:pubmed
pubmed-article:8655955pubmed:meshHeadingpubmed-meshheading:8655955-...lld:pubmed
pubmed-article:8655955pubmed:meshHeadingpubmed-meshheading:8655955-...lld:pubmed
pubmed-article:8655955pubmed:meshHeadingpubmed-meshheading:8655955-...lld:pubmed
pubmed-article:8655955pubmed:meshHeadingpubmed-meshheading:8655955-...lld:pubmed
pubmed-article:8655955pubmed:meshHeadingpubmed-meshheading:8655955-...lld:pubmed
pubmed-article:8655955pubmed:year1995lld:pubmed
pubmed-article:8655955pubmed:articleTitlePlasma endotoxin and tumor necrosis factor-alpha in the hyperkinetic state of cirrhosis.lld:pubmed
pubmed-article:8655955pubmed:affiliationLaboratoire d'Hémodynamique Splanchnique, Unité de Recherches de Physiopathologie Hépatique (INSERM U-24), Hôpital Beaujon, Clichy, France.lld:pubmed
pubmed-article:8655955pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8655955lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8655955lld:pubmed